Cadinha & Co. LLC Acquires 6,800 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cadinha & Co. LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.7% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 64,943 shares of the medical equipment provider's stock after buying an additional 6,800 shares during the period. Intuitive Surgical accounts for approximately 5.6% of Cadinha & Co. LLC's portfolio, making the stock its 3rd largest position. Cadinha & Co. LLC's holdings in Intuitive Surgical were worth $33,898,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Clarius Group LLC increased its stake in shares of Intuitive Surgical by 11.8% during the fourth quarter. Clarius Group LLC now owns 2,089 shares of the medical equipment provider's stock worth $1,090,000 after acquiring an additional 220 shares during the period. Oak Ridge Investments LLC boosted its holdings in Intuitive Surgical by 69.2% in the 4th quarter. Oak Ridge Investments LLC now owns 17,021 shares of the medical equipment provider's stock valued at $8,884,000 after purchasing an additional 6,961 shares in the last quarter. BNC Wealth Management LLC increased its position in Intuitive Surgical by 5.7% during the 4th quarter. BNC Wealth Management LLC now owns 11,148 shares of the medical equipment provider's stock worth $5,819,000 after purchasing an additional 603 shares during the period. Moss Adams Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 14.4% during the 4th quarter. Moss Adams Wealth Advisors LLC now owns 717 shares of the medical equipment provider's stock worth $374,000 after buying an additional 90 shares in the last quarter. Finally, Riversedge Advisors LLC lifted its holdings in shares of Intuitive Surgical by 5.1% in the 4th quarter. Riversedge Advisors LLC now owns 849 shares of the medical equipment provider's stock valued at $443,000 after buying an additional 41 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Up 1.5 %

NASDAQ:ISRG traded up $8.56 on Friday, hitting $592.64. 2,630,118 shares of the stock were exchanged, compared to its average volume of 1,158,623. The stock has a fifty day moving average of $540.66 and a 200-day moving average of $499.19. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68. The stock has a market cap of $211.09 billion, a PE ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ISRG. Raymond James increased their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research report on Monday, October 14th. Truist Financial raised their price objective on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a "buy" rating in a research note on Wednesday, December 18th. Citigroup upped their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Stifel Nicolaus boosted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday, December 5th. Finally, BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $554.17.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 108 shares of the business's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares of the company's stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,190 shares of company stock valued at $25,012,927. Corporate insiders own 0.80% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.